ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,862Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1171

$1.42M Total Retail Price of All Prescriptions

Rank: 20 out of 1171

976 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 976 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 976 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 20,984 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,482 999 S3 1 8
LEVOTHYROXINE SODIUM 1,251 1,050 2 4
OMEPRAZOLE 945 730 3 5
PRAVASTATIN SODIUM 831 661 4 13
FUROSEMIDE 757 612 5 6
LISINOPRIL 711 542 6 3
WARFARIN SODIUM 642 569 7 12
AMLODIPINE BESYLATE 629 501 8 2
SIMVASTATIN 563 425 9 1
SERTRALINE HCL 499 366 10 23
GABAPENTIN 433 223 11 16
METOPROLOL TARTRATE 416 339 12 11
POTASSIUM CHLORIDE 396 344 13 19
ALLOPURINOL 381 314 14 31
METOPROLOL SUCCINATE 362 341 15 17
ATORVASTATIN CALCIUM 357 303 16 10
LOVASTATIN 351 294 17 36
GLIPIZIDE 336 260 18 47
CEPHALEXIN 332 247 19 104
LOSARTAN POTASSIUM 315 291 20 14
METFORMIN HCL ER 289 221 21 52
RANITIDINE HCL 284 224 22 38
CITALOPRAM HBR 280 183 23 22
KLOR-CON M20 251 210 24 41
MELOXICAM 241 188 25 56
HYDROCHLOROTHIAZIDE 235 196 26 9
ZOLPIDEM TARTRATE 231 127 27 21
TRAZODONE HCL 215 137 28 37
FLUTICASONE PROPIONATE 213 167 29 30
CRESTOR 207 198 30 27
MORPHINE SULFATE ER 199 99 S2 31 146
METFORMIN HCL 198 141 32 7
TRIAMTERENE-HCTZ 195 145 33 58
NEXIUM 192 131 34 25
ISOSORBIDE MONONITRATE ER 184 143 35 44
PANTOPRAZOLE SODIUM 173 123 36 29
FENTANYL 173 142 S2 36 89
CLOPIDOGREL 171 152 38 35
SPIRONOLACTONE 169 115 39 53
PREDNISONE 167 140 40 39
TAMSULOSIN HCL 166 136 41 28
OXYCODONE HCL 165 47 S2 42 79
ALENDRONATE SODIUM 159 146 43 33
ATENOLOL 153 127 44 15
DONEPEZIL HCL 152 142 45 24
CYCLOBENZAPRINE HCL 152 83 R 45 67
AMOX TR-POTASSIUM CLAVULANATE 136 105 47 142
CIPROFLOXACIN HCL 134 103 48 61
PROMETHAZINE HCL 133 79 R 49 87
SPIRIVA 130 75 50 57
CARVEDILOL 130 129 50 20
AMITRIPTYLINE HCL 129 109 R 52 74
GLIPIZIDE ER 129 108 52 86
MIRTAZAPINE 126 94 54 50
PROAIR HFA 122 48 55 49
TRAMADOL HCL 117 92 56 18
ZETIA 116 114 57 63
OXYCODONE HCL-ACETAMINOPHEN 112 42 S2 58 99
VENLAFAXINE HCL ER 112 78 58 113
PLAVIX 112 97 58 55
LOSARTAN-HYDROCHLOROTHIAZIDE 108 87 61 40
ENDOCET 105 57 S2 62 161
GLIMEPIRIDE 105 84 62 34
LANTUS SOLOSTAR 102 73 64 90
FLUOXETINE HCL 100 57 65 76
AZITHROMYCIN 100 68 65 43
IBUPROFEN 99 61 67 80
VERAPAMIL ER 95 87 68 91
DICLOFENAC SODIUM 93 61 69 103
CYMBALTA 92 61 70 64
AMLODIPINE BESYLATE-BENAZEPRIL 91 74 71 70
PEN NEEDLE 91 65 71 122
FENOFIBRATE 91 46 71 81
TOPIRAMATE 90 19 74 196
DIOVAN 90 86 74 32
LANSOPRAZOLE 87 55 76 150
DILTIAZEM 24HR CD 84 81 77 101
ENALAPRIL MALEATE 84 56 77 73
OXYBUTYNIN CHLORIDE 84 41 77 171
DILTIAZEM 24HR ER 82 71 80 112
METHADONE HCL 81 24 S2 81 144
QUINAPRIL HCL 80 80 82 156
ESTRADIOL 80 39 R 82 284
LYRICA 80 29 82 127
TRIAMTERENE-HYDROCHLOROTHIAZID 79 66 85 202
CLONIDINE HCL 78 54 86 45
SYNTHROID 78 59 86 48
PAROXETINE HCL 77 66 88 62
SYMBICORT 75 55 89 178
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 51 89 26
MECLIZINE HCL 74 67 91 115
BACLOFEN 74 43 91 110
NAPROXEN 74 53 91 95
ROPINIROLE HCL 73 49 94 119
BENAZEPRIL HCL 71 56 95 83
NYSTATIN 69 51 96 128
POLYETHYLENE GLYCOL 3350 68 67 97 72
CILOSTAZOL 67 65 98 271
ABILIFY 66 19 99 175
ADVAIR DISKUS 66 41 99 51
INSULIN SYRINGE 66 44 99 71
FINASTERIDE 65 60 102 88
BUSPIRONE HCL 63 27 103 129
DIGOXIN 63 63 103 68
CELEBREX 63 60 103 100
OXYCONTIN 62 30 S2 106 186
NAMENDA 62 60 106 42
ESCITALOPRAM OXALATE 60 18 108 69
DEXILANT 59 44 109 239
RAMIPRIL 59 58 109 85
TERAZOSIN HCL 57 54 111 143
LIPITOR 55 47 112 92
CARBIDOPA-LEVODOPA 54 28 113 107
SUMATRIPTAN SUCCINATE 50 38 114 463
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.